Keytruda combo gets regular approval for first-line non-squamous NSCLC

FDA granted regular approval to Keytruda pembrolizumab from

Read the full 86 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE